Cover Image

Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India

Saved in:

Bibliographic Details
Main Authors:	Philip Raj Abraham (Author), Vijesh Sreedhar Kuttiatt (Author), Manju Rahi (Author), Ashwani Kumar (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study
by: Muhammed Jabir, et al.
Published: (2024)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008)

Mass Drug Administration for Lymphatic Filariasis Elimination in Two Districts of North Karnataka: Coverage and Compliance Assessment
by: Huluvadi Shivalingaiah Anwith, et al.
Published: (2020)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013)

National mass drug administration costs for lymphatic filariasis elimination.
by: Ann S Goldman, et al.
Published: (2007)

A Study of Coverage and Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Rewa District Of Madhya Pradesh
by: Amarnath Gupta, et al.
Published: (2014)

A Study on Coverage Evaluation, Compliance and Awareness of Mass Drug Administration for Elimination of Lymphatic Filariasis in Osmanabad District
by: Lata B Godale, et al.
Published: (2012)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011)

Coverage And Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Endemic Areas of Sagar and Damoh Districts, Madhya Pradesh
by: Arvind Sharma, et al.
Published: (2013)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)

Evaluation Of Coverage and Compliance of Mass Drug Administration Programme 2011 For Elimination of Lymphatic Filariasis in Nalgonda District Of Andhra Pradesh, India
by: Abhay S Nirgude, et al.
Published: (2012)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
by: Purushothaman Jambulingam, et al.
Published: (2021)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012)

Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
by: Reza A Niles, et al.
Published: (2021)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
by: Carmen Maroto-Camino, et al.
Published: (2019)

FILARIASIS DISTRIBUTION AND COVERAGE OF MASS DRUG ADMINISTRATION
by: Ikha Solikha, et al.
Published: (2019)

Empowering lymphatic filariasis affected individuals in India: acknowledging disability status and ensuring justice
by: Sam Joy, et al.
Published: (2024)

Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India
by: P. Ratna, et al.
Published: (2024)

Global elimination of lymphatic filariasis: a "mass uprising of compassion".
by: David G Addiss
Published: (2013)

Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.
by: Hugues C Nana-Djeunga, et al.
Published: (2015)

The role of 'omics' in the quest to eliminate human filariasis.
by: Sara Lustigman, et al.
Published: (2017)

Progress towards global elimination of lymphatic filariasis
by: Joseph Kamgno, et al.
Published: (2020)

The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem.
by: Indeewarie E Gunaratna, et al.
Published: (2024)

Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021.
by: Claudia Duguay, et al.
Published: (2024)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021)

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
by: Frank O Richards, et al.
Published: (2011)

Population migration: implications for lymphatic filariasis elimination programmes.
by: K D Ramaiah
Published: (2013)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
by: Yakuba M Bah, et al.
Published: (2020)

Mid-term assessment of the lymphatic filariasis elimination program
by: Saurabh Rambiharilal Shrivastava, et al.
Published: (2016)

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
by: Paul T Cantey, et al.
Published: (2010)

Perceived threat and benefit toward community compliance of filariasis’ mass drug administration in Pekalongan district, Indonesia
by: Widjanarko B, et al.
Published: (2018)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
by: Charles W Goss, et al.
Published: (2019)

Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China
by: Yuan Fang, et al.
Published: (2019)

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
by: Anjali Modi, et al.
Published: (2021)

Elimination of lymphatic filariasis as a public health problem in Malawi.
by: John Chiphwanya, et al.
Published: (2024)

Global elimination of lymphatic filariasis: addressing the public health problem.
by: David G Addiss
Published: (2010)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Vivax malaria: a possible stumbling block for malaria elimination in India
by: Ashwani Kumar, et al.
Published: (2024)